SUBSCRIBE
SUBSCRIBE
News   Policy

Galenica Pharmaceuticals, Daiichi Sankyo, Inc. Drug Poses Risks, U.S. FDA Staff Says

January 31, 2008 | 
1 min read
Jan. 30 (Bloomberg) -- Daiichi Sankyo Co.'s drug Injectafer, which the company proposed selling for iron deficiency anemia, may pose ``serious safety concerns,'' U.S. regulators said.
Regulatory Europe
Food and Drug Administration (FDA) Daiichi Sankyo
MORE ON THIS TOPIC
NIAID Director Dr. Jeanne Marrazzo addresses staff. She is wearing a black and white shirt, black pants, and round glasses.
Regulatory
Fired NIAID Director Claims Ouster Was Payback for Whistleblower Report
October 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Stack of coins balancing on seesaw over a bottle of pills.
Drug pricing
CMS Finalizes Stronger Protections for Orphan Drugs Against IRA Price Negotiations
October 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone collage. Concept of choice, make a decision left or right, ability to think in a difficult situation, question of choosing between 2 directions. Illustration for web banner, social media banner. Vector illustration
Tariffs
Trump Delays Pharma Tariffs Yet Again
October 2, 2025
 · 
2 min read
 · 
Tristan Manalac
Difficult question concept. Big question mark or big problem to solve or finding solution, doubt or uncertainty, thinking to make decision, businessman holds up big question mark.
Drug pricing
Pfizer’s Drug Pricing Deal With Trump Raises Questions About Access
October 1, 2025
 · 
2 min read
 · 
Dan Samorodnitsky